LEXX
NASDAQ · Pharmaceuticals
Lexaria Bioscience Corp
$4.58
+0.41 (+9.83%)
Open$4.11
Previous Close$4.17
Day High$4.58
Day Low$4.10
52W High$21.60
52W Low$2.43
Volume—
Avg Volume41.9K
Market Cap7.35M
P/E Ratio—
EPS$-3.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+477.1% upside
Current
$4.58
$4.58
Target
$26.43
$26.43
$20.55
$26.43 avg
$40.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.24M | 888.3K | 9.47M |
| Net Income | -20,893,388 | -13,478,638 | 1.90M |
| Profit Margin | -1,686.0% | -1,601.7% | 20.1% |
| EBITDA | -20,756,253 | -14,134,069 | 3.60M |
| Free Cash Flow | — | — | 1.11M |
| Rev Growth | +39.5% | +39.5% | +1.1% |
| Debt/Equity | — | — | 0.74 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,364.73 | -3.76% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $272.32 | -1.45% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $146.94 | -2.27% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.88 | -2.96% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $63.13 | -1.65% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $82.11 | -7.95% | 12.3 | 32.24B |